AllianceBernstein
INFI

AllianceBernstein’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

AllianceBernstein’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,200
Closed -$18K – 3431
2022
Q1 		$18K Buy
16,200
+100
+0.6% +$120 ﹤0.01% 3222
2021
Q4 		$36K Hold
16,100
– – ﹤0.01% 3254
2021
Q3 		$55K Hold
16,100
– – ﹤0.01% 3224
2021
Q2 		$48K Buy
+16,100
New +$50.9K ﹤0.01% 3277
2017
Q2 		– Sell
-110,000
Closed -$355K – 3191
2017
Q1 		$355K Sell
110,000
-1,300
-1% -$3.2K ﹤0.01% 2645
2016
Q4 		$150K Sell
111,300
-910
-0.8% -$1.19K ﹤0.01% 2938
2016
Q3 		$175K Hold
112,210
– – ﹤0.01% 2869
2016
Q2 		$149K Buy
112,210
+43,000
+62% +$201K ﹤0.01% 2856
2016
Q1 		$365K Hold
69,210
– – ﹤0.01% 2517
2015
Q4 		$543K Sell
69,210
-10,100
-13% -$86.9K ﹤0.01% 2415
2015
Q3 		$670K Sell
79,310
-65,020
-45% -$600K ﹤0.01% 2370
2015
Q2 		$1.58M Buy
144,330
+64,930
+82% +$833K ﹤0.01% 1985
2015
Q1 		$1.11M Hold
79,400
– – ﹤0.01% 2125
2014
Q4 		$1.34M Hold
79,400
– – ﹤0.01% 2020
2014
Q3 		$1.07M Sell
79,400
-3,400
-4% -$40.5K ﹤0.01% 2155
2014
Q2 		$1.05M Hold
82,800
– – ﹤0.01% 2216
2014
Q1 		$984K Sell
82,800
-5,100
-6% -$68.4K ﹤0.01% 2173
2013
Q4 		$1.21M Sell
87,900
-7,762
-8% -$110K ﹤0.01% 2048
2013
Q3 		$1.67M Sell
95,662
-15,089
-14% -$289K ﹤0.01% 1816
2013
Q2 		$1.8M Buy
+110,751
New +$3.43M ﹤0.01% 1676

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AllianceBernstein's INFI Position: Q2 2022 in Review

AllianceBernstein sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 16,200 shares — an estimated $18K sold.

AllianceBernstein first reported a position in INFI in Q2 2013 and held it in 20 quarters. The position peaked at $1.8M in Q2 2013. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • AllianceBernstein reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 16,200 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $18K.
  • AllianceBernstein first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • AllianceBernstein's Infinity Pharmaceuticals, Inc. position peaked at $1.8M in Q2 2013.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.